Screener
ClearPoint Neuro CLPT Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Other income (expense): | ||
| Other (expense) income, net | (35) | 4 |
| Interest income | 351 | 151 |
| Interest expense | (1,382) | — |
| Net loss before income taxes | (9,544) | (6,008) |
| Income tax expense | 8 | 18 |
| Net loss | $(9,552) | $(6,026) |
| Net loss per share attributable to common stockholders: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's interest expense?
- ClearPoint Neuro (CLPT) reported interest expense of $1.38M in Q1 2026.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about ClearPoint Neuro's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude